Chemistry:Imofinostat
From HandWiki
Imofinostat is an investigational new drug that is being developed by Formosa Pharmaceuticals and Anbogen Therapeutics for the treatment of colorectal cancer. It is a histone deacetylase inhibitor with selectivity for HDAC3.[1][2]
References
- ↑ "Imofinostat". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800044855.
- ↑ "Imofinostat, a histone deacetylase inhibitor, enhances anti-tumoral activity on colorectal cancer with an immune checkpoint inhibitor.". Cancer Research 86 (7_Supplement). April 2026. doi:10.1158/1538-7445.AM2026-4497.
 |  |
